Publications by authors named "Cristina Papayannidis"

73Publications

MDM2 inhibition: an important step forward in cancer therapy.

Leukemia 2020 Nov 10;34(11):2858-2874. Epub 2020 Jul 10.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0949-zDOI Listing
November 2020

Acute Myeloid Leukemia Mutations: Therapeutic Implications.

Int J Mol Sci 2019 Jun 3;20(11). Epub 2019 Jun 3.

Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli", S.Orsola-Malpighi Hospital, 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20112721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600275PMC
June 2019

Leukemia cutis in a Ph+ ALL patient treated with ponatinib.

G Ital Dermatol Venereol 2018 Oct;153(5):730-731

Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.17.05647-4DOI Listing
October 2018

Blinatumomab in Ph+ B-ALL: present and perspectives.

Oncotarget 2017 Nov 25;8(55):93309-93310. Epub 2017 Oct 25.

Cristina Papayannidis: Institute of Hematology and Medical Oncology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706793PMC
November 2017

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.

BMC Cancer 2017 Aug 5;17(1):523. Epub 2017 Aug 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Via Massarenti, 9-40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3511-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545087PMC
August 2017

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.

J Clin Oncol 2017 Jun 29;35(16):1795-1802. Epub 2017 Mar 29.

Giovanni Martinelli and Cristina Papayannidis, Institute of Hematology and Medical Oncology "L. and A. Seràgnoli", Bologna; Alessandro Rambaldi, University of Milan Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; Nicolas Boissel, University Paris Diderot, Hôpital Saint-Louis, Paris; Patrice Chevallier, Centre Hospitalier Universitaire Nantes, Nantes, France; Oliver Ottmann, Cardiff University, Cardiff; Adele K. Fielding, University College London Cancer Institute, London, United Kingdom; Nicola Gökbuget, University Hospital, Goethe University, Frankfurt; Max S. Topp, Universitätsklinikum Würzburg, Würzburg, Germany; Ellen K. Ritchie, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY; Lulu Ren Sterling, Amgen, San Francisco; Jonathan Benjamin, Amgen, Thousand Oaks; and Anthony Stein, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.3531DOI Listing
June 2017

Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML.

Expert Opin Pharmacother 2016 Dec 21;17(18):2479-2486. Epub 2016 Nov 21.

a Institute of Hematology L. e A. Seràgnoli , Universita degli Studi di Bologna Azienda Ospedaliera Sant\'Orsola-Malpighi Ringgold standard institution , Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1258056DOI Listing
December 2016

Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives.

Ann Hematol 2016 Apr 19;95(5):681-93. Epub 2016 Feb 19.

Department of Hematology/Oncology "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2617-yDOI Listing
April 2016

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.

Genes Chromosomes Cancer 2016 Apr 27;55(4):375-88. Epub 2016 Jan 27.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology and Medical Oncology "Seragnoli," Sant'Orsola-Malpighi Hospital-University, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22341DOI Listing
April 2016

FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.

Am J Hematol 2016 Mar;91(3):E14-6

Institute of Hematology and Medical Oncology "Lorenzo E Ariosto Seràgnoli", Sant'Orsola-Malpighi Hospital-University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24276DOI Listing
March 2016

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Curr Cancer Drug Targets 2013 Sep;13(7):791-810

Institute of Hematology "L. e A. Seràgnoli" Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy, Via Massarenti, 9 - 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104470PMC
http://dx.doi.org/10.2174/15680096113139990089DOI Listing
September 2013

A case report of acute myeloid leukemia and neurofibromatosis 1.

Hematol Rep 2013 Jun 3;5(2):28-9. Epub 2013 Jul 3.

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2013.e8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719102PMC
June 2013

Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments.

Curr Hematol Malig Rep 2012 Jun;7(2):133-43

Department of Hematology and Oncological Sciences L. and A. Seràgnoli, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-012-0122-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342501PMC
June 2012

Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.

Am J Hematol 2010 Aug;85(8):608

Institute of Hematology/Oncology "L. and A. Seràgnoli," S.Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.21719
Publisher Site
http://dx.doi.org/10.1002/ajh.21719DOI Listing
August 2010

New targets for Ph+ leukaemia therapy.

Best Pract Res Clin Haematol 2009 Sep;22(3):445-54

Department of Hematology/Oncology L. and A. Seràgnoli S.Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.08.002DOI Listing
September 2009

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.

Hematology 2008 Feb;13(1):1-12

Institute of Hematology and Medical Oncology L. e A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/102453308X315753DOI Listing
February 2008

Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.

Br J Haematol 2006 Aug;134(4):356

Institute of Haematology and Medical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06168.xDOI Listing
August 2006